The FDA delivered two notable approvals for RSV immunization, UroGen overcame a negative advisory committee vote to secure an ...

An outside group of experts agreed that the CDC should recommend a new antibody drug that offers protection against RSV for ...

A newly configured federal vaccine panel's June 25 action is expected to improve options to protect infants from potentially ...

A major UK-led clinical trial has found that a treatment commonly used to help premature babies breathe offers no benefit for ...

A medical panel appointed by Health Secretary Robert F. Kennedy Jr. voted Thursday to recommend a new antibody treatment ...

A medical panel appointed by Health Secretary Robert F. Kennedy Jr. voted Thursday to recommend a new antibody treatment ...

A new national guideline provides evidence-based recommendations for diagnosing, treating, and preventing pediatric ...

On day one of the highly anticipated first meeting of the CDC's newly formed vaccine advisory committee, members debated the ...

A virus that once filled pediatric hospital beds and terrified new parents is finally being pushed back—before babies are ...

Respiratory syncytial virus (RSV) is a leading cause of acute lower respiratory infections (ALRTIs) in children under five and poses a persistent threat to child health worldwide.

RSV is the focus of a new national pediatric guideline in China aimed at standardizing diagnosis, treatment, and prevention strategies for respiratory tract infections in children ...